Congfang Zhang

Statistics

Publications

Citations

448

H-Index

Active since

2010

Affiliations

The University of Texas Medical Branch at Galveston(Current)

Baylor College of Medicine

Congfang Zhang is an author at The University of Texas Medical Branch at Galveston specializing in atherosclerosis, cardiovascular disease, and cardiovascular pharmacology.

Top concepts

MedicineCardiologyPhysiologyThrombosisPharmacologyHeart FailureAtherosclerosisPharmacotherapyCardiovascular DiseaseCardiovascular Pharmacology

Publications per year

2010–2010

Publications

Downregulation of microRNA-29 by antisense inhibitors and a PPAR-γ agonist protects against myocardial ischaemia–reperfusion injury

Yumei Ye, Zhaoyong Hu, Yu Lin et al. · Cardiovascular Research · 2010 · 201 citations

The myocardial infarct size-limiting effect of sitagliptin is PKA-dependent, whereas the protective effect of pioglitazone is partially dependent on PKA

Yumei Ye, Kyle T. Keyes, Congfang Zhang et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2010 · 151 citations

Heart Failure, Cardiovascular Pharmacology, Pharmacotherapy +17

Pharmacological inhibition of PTEN limits myocardial infarct size and improves left ventricular function postinfarction

Kyle T. Keyes, Jing Xu, Bo Long et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2010 · 96 citations

Cardiac Muscle, Heart Failure, Cardiovascular Pharmacology +19

1–3 of 3